Roche enters a broad strategic collaboration with Foundation Medicine in the field of molecular information in oncology
- Details
- Category: Roche

MedImmune enters licensing agreement with Omnis Pharmaceuticals for oncolytic viruses in immuno-oncology
- Details
- Category: AstraZeneca

Acquisition provides Pfizer with a preclinical CMV vaccine candidate
- Details
- Category: Pfizer

Novartis collaborates with Intellia Therapeutics and Caribou Biosciences
- Details
- Category: Novartis

Bristol-Myers Squibb and California Institute for Biomedical Research (Calibr) sign worldwide research collaboration
- Details
- Category: Bristol-Myers Squibb

New European consortium formed to help further advance development of a GSK/NIH Ebola candidate vaccine
- Details
- Category: GlaxoSmithKline

Abbott completes acquisition of Veropharm
- Details
- Category: Abbott

More Pharma News ...
- Pfizer expands rare disease research with establishment of gene therapy platform
- Jury verdict favours AstraZeneca in Nexium antitrust litigation
- Bristol-Myers Squibb Foundation awards nine grants to support care for high-risk patients with hepatitis B and C in China and India
- Amgen and AstraZeneca announce positive results from third and final pivotal Phase III study of Brodalumab in patients with moderate-to-severe plaque psoriasis
- GSK statement on first phase 1 trial results of a candidate Ebola vaccine
- Bristol-Myers Squibb and Five Prime Therapeutics announce exclusive clinical collaboration
- Novartis Foundation symposium showcases sustainable healthcare interventions